sy 5609 (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
94
Structured Review
MedChemExpress
sy 5609
Sy 5609, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sy+5609/SY-5609/10__1158_slash_1535___7163__mct___25___1529-49-10-33
Average 94 stars, based on 9 article reviews
Sy 5609, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sy+5609/SY-5609/10__1158_slash_1535___7163__mct___25___1529-49-10-33
Average 94 stars, based on 9 article reviews
sy 5609 - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Incubation:Article Title: CDK7 is a novel therapeutic target in fibrolamellar carcinoma Article Snippet: Approximately 2.0 × 10 4 purified PHH cells/well were seeded in rat tail collagen (collagen type I) (Life Technologies, Carlsbad, CA) coated 96-well plate and incubated in hepatocyte Incubation medium at 37 °C and 5% CO 2 . .. Twenty-four hours after incubation, PHHs were treated with Article Title: CDK7 is a novel therapeutic target in fibrolamellar carcinoma Article Snippet: .. To investigate the synergistic effect between Article Title: CDK7 is a novel therapeutic target in fibrolamellar carcinoma Article Snippet: To measure the apoptosis activity in HepG2 cells and HepG2 DNAJB1-PRKACA clones, we used Caspase-Glo 3/7 and 8 assay systems (Promega, Madison, WI). .. Approximately 2.0 × 10 3 cells/well were seeded in a 96-well plate and (1) incubated in RPMI1640 culture medium over 4 days at 37 °C and 5% CO 2 or (2) incubated in RPMI1640 culture medium containing Article Title: CDK7 is a novel therapeutic target in fibrolamellar carcinoma Article Snippet: .. HepG2 and HepG2 DNAJB1-PRKACA clones were incubated with RPMI1640 cell culture for 24 hours, treated with Article Title: CDK7 is a novel therapeutic target in fibrolamellar carcinoma Article Snippet: .. After incubation, cells were treated with Cell Culture:Article Title: CDK7 is a novel therapeutic target in fibrolamellar carcinoma Article Snippet: .. To investigate the synergistic effect between Article Title: CDK7 is a novel therapeutic target in fibrolamellar carcinoma Article Snippet: .. HepG2 and HepG2 DNAJB1-PRKACA clones were incubated with RPMI1640 cell culture for 24 hours, treated with Clone Assay:Article Title: CDK7 is a novel therapeutic target in fibrolamellar carcinoma Article Snippet: .. HepG2 and HepG2 DNAJB1-PRKACA clones were incubated with RPMI1640 cell culture for 24 hours, treated with other:Article Title: Sensitivity of pancreatic adenocarcinoma cells to blockade of post-initiation CDK-dependent Pol II transcription cycle checkpoints Article Snippet: CCT-251921 (HY-19984, (59)), OTS964 (HY-160 12467, (60)), THZ531 (HY-103618, (61)), SY-5609 (HY-138293, (62)), CR8 (HY-18340, (63)), 161 Trametinib (HY-10999), Binimetinib (HY-15202), Sotorasib (HY-114277), Adagrasib (HY-162 130149), and MRTX1133 (HY-164813, (14)) were purchased from |